Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ZUBAIR FAROOQUI

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1821001835
CMS profile
354724
Location
TAMPA, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$1,647.23

81 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,647.23 81

By paying entity

PY2024 · entire year · sorted by reported total

Page 2 of 2; records 51–81 of 81 matching records. This page contains 31 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ZUBAIR FAROOQUI

NPI 1821001835 · CMS profile ID 354724

Allopathic & Osteopathic Physicians / Internal Medicine

TAMPA, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–81 of 81 matching records. This page contains 31 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1821001835?year=2024&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ZUBAIR FAROOQUI, NPI 1821001835, CMS profile ID 354724. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–81 of 81 matching records. This page contains 31 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1821001835?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). ZUBAIR FAROOQUI, NPI 1821001835, CMS profile ID 354724. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–81 of 81 matching records. This page contains 31 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1821001835?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
ZUBAIR FAROOQUI, NPI 1821001835, CMS profile ID 354724, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–81 of 81 matching records. This page contains 31 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1821001835?year=2024&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

81 matching records · $1,647.23 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 81 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–81 of 81.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AstraZeneca Pharmaceuticals LP $18.6205/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105770994 CMS
ALK-Abello, Inc $21.4005/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1099890583 CMS
AstraZeneca Pharmaceuticals LP $14.0105/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104639005 CMS
Lilly USA, LLC $24.0805/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135508082 CMS
GlaxoSmithKline, LLC. $18.3204/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116029049 CMS
ABBVIE INC. $20.4704/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103712633 CMS
PFIZER INC. $19.4504/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131267219 CMS
Bayer Healthcare Pharmaceuticals Inc. $28.8704/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086186366 CMS
PFIZER INC. $11.9504/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131561135 CMS
GlaxoSmithKline, LLC. $20.2304/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116670312 CMS
PFIZER INC. $11.5703/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131562020 CMS
ALK-Abello, Inc $14.7203/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1099890581 CMS
Novo Nordisk Inc $19.2003/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1096776832 CMS
Lilly USA, LLC $27.9303/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135521665 CMS
Lilly USA, LLC $22.0303/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1135508080 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $28.9403/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1118166556 CMS
Exact Sciences Corporation $17.0303/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1114653760 CMS
Amgen Inc. $18.4803/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117551579 CMS
Novo Nordisk Inc $4.2602/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1096889276 CMS
Novo Nordisk Inc $17.9702/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1097290175 CMS
ABBVIE INC. $28.8202/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103712631 CMS
AstraZeneca Pharmaceuticals LP $14.8802/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105839827 CMS
GlaxoSmithKline, LLC. $16.2402/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116693867 CMS
Bayer Healthcare Pharmaceuticals Inc. $31.7302/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086130130 CMS
AstraZeneca Pharmaceuticals LP $20.8802/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105704788 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $22.2702/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1153537726 CMS
GlaxoSmithKline, LLC. $16.3901/31/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116615368 CMS
AIMMUNE THERAPEUTICS, INC. $27.3501/25/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1147017057 CMS
ABBVIE INC. $24.9601/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1103712629 CMS
PFIZER INC. $22.4601/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131163783 CMS
PFIZER INC. $25.9701/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1130984662 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $863.99 33
PY2020 $911.95 54
PY2021 $1,529.86 88
PY2022 $1,273.80 70
PY2023 $2,760.86 89
PY2024 $1,647.23 81
PY2025 $1,689.99 69

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $176,571.06 40
PY2024 Principal investigator $163,885.24 32
PY2023 Principal investigator $379,434.00 38
PY2022 Principal investigator $26.64 2

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

40 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 F. Hoffmann-La Roche AG $2,250.00 12/19/2025 Non-covered Recipient Entity
THEIA CLINICAL RESEARCH CENTERS LLC
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease (SIBERITE-1) No dispute reported 06/30/2026 1211672130
Principal investigator 1 F. Hoffmann-La Roche AG $68.00 12/19/2025 Non-covered Recipient Entity
THEIA CLINICAL RESEARCH CENTERS LLC
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease (SIBERITE-1) No dispute reported 06/30/2026 1211672134
Principal investigator 1 F. Hoffmann-La Roche AG $5,000.00 12/19/2025 Non-covered Recipient Entity
THEIA CLINICAL RESEARCH CENTERS LLC
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease (SIBERITE-1) No dispute reported 06/30/2026 1211672137
Principal investigator 1 F. Hoffmann-La Roche AG $1,750.00 12/19/2025 Non-covered Recipient Entity
THEIA CLINICAL RESEARCH CENTERS LLC
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease (SIBERITE-1) No dispute reported 06/30/2026 1211672142
Principal investigator 1 F. Hoffmann-La Roche AG $1,483.00 12/19/2025 Non-covered Recipient Entity
THEIA CLINICAL RESEARCH CENTERS LLC
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease (SIBERITE-1) No dispute reported 06/30/2026 1211672146
Principal investigator 1 F. Hoffmann-La Roche AG $2,739.00 12/19/2025 Non-covered Recipient Entity
THEIA CLINICAL RESEARCH CENTERS LLC
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease (SIBERITE-1) No dispute reported 06/30/2026 1211672149
Principal investigator 1 Genentech, Inc. $3,635.00 12/03/2025 Non-covered Recipient Entity
THEIA CLINICAL RESEARCH CENTERS LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211672230
Principal investigator 1 Genentech, Inc. $11,140.50 10/22/2025 Non-covered Recipient Entity
THEIA CLINICAL RESEARCH CENTERS LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211672211
Principal investigator 1 Genentech, Inc. $2,700.00 10/03/2025 Non-covered Recipient Entity
THEIA CLINICAL RESEARCH CENTERS LLC
UC P3: Double-Blind Treat Straight Through No dispute reported 06/30/2026 1211672213
Principal investigator 1 Genentech, Inc. $3,250.00 10/03/2025 Non-covered Recipient Entity
THEIA CLINICAL RESEARCH CENTERS LLC
UC P3: Double-Blind Treat Straight Through No dispute reported 06/30/2026 1211672217
Principal investigator 1 Genentech, Inc. $2,500.00 10/03/2025 Non-covered Recipient Entity
THEIA CLINICAL RESEARCH CENTERS LLC
UC P3: Double-Blind Treat Straight Through No dispute reported 06/30/2026 1211672221
Principal investigator 1 Genentech, Inc. $13,150.00 10/03/2025 Non-covered Recipient Entity
THEIA CLINICAL RESEARCH CENTERS LLC
UC P3: Double-Blind Treat Straight Through No dispute reported 06/30/2026 1211672226
Principal investigator 1 Janssen Research & Development, LLC $1,280.38 07/28/2025 Non-covered Recipient Entity
Theia Clinic Rsrch Centers Llc
A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years No dispute reported 06/30/2026 1175187539
Principal investigator 1 Janssen Research & Development, LLC $2,074.84 07/16/2025 Non-covered Recipient Entity
Theia Clinic Rsrch Centers Llc
A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years No dispute reported 06/30/2026 1175187676
Principal investigator 1 Janssen Research & Development, LLC $6,733.84 07/16/2025 Non-covered Recipient Entity
Theia Clinic Rsrch Centers Llc
A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years No dispute reported 06/30/2026 1175187705
Principal investigator 1 Janssen Research & Development, LLC $7,682.28 06/20/2025 Non-covered Recipient Entity
Theia Clinic Rsrch Centers Llc
A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years No dispute reported 06/30/2026 1175187453
Principal investigator 1 Genentech, Inc. $929.00 05/23/2025 Non-covered Recipient Entity
THEIA CLINICAL RESEARCH CENTERS LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211672190
Principal investigator 1 Janssen Research & Development, LLC $5,121.52 05/20/2025 Non-covered Recipient Entity
Theia Clinic Rsrch Centers Llc
A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years No dispute reported 06/30/2026 1175187598
Principal investigator 1 Genentech, Inc. $6,500.00 05/02/2025 Non-covered Recipient Entity
THEIA CLINICAL RESEARCH CENTERS LLC
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease (SIBERITE-1) No dispute reported 06/30/2026 1211672178
Principal investigator 1 Genentech, Inc. $11,500.00 05/02/2025 Non-covered Recipient Entity
THEIA CLINICAL RESEARCH CENTERS LLC
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease (SIBERITE-1) No dispute reported 06/30/2026 1211672181
Principal investigator 1 Genentech, Inc. $900.00 05/02/2025 Non-covered Recipient Entity
THEIA CLINICAL RESEARCH CENTERS LLC
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease (SIBERITE-1) No dispute reported 06/30/2026 1211672185
Principal investigator 1 Genentech, Inc. $2,700.00 05/02/2025 Non-covered Recipient Entity
THEIA CLINICAL RESEARCH CENTERS LLC
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease (SIBERITE-1) No dispute reported 06/30/2026 1211672188
Principal investigator 1 Genentech, Inc. $929.00 04/30/2025 Non-covered Recipient Entity
THEIA CLINICAL RESEARCH CENTERS LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211672198
Principal investigator 1 Janssen Research & Development, LLC $18,291.32 04/29/2025 Non-covered Recipient Entity
Theia Clinic Rsrch Centers Llc
A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years No dispute reported 06/30/2026 1175187411
Principal investigator 1 Janssen Research & Development, LLC $10,559.00 04/29/2025 Non-covered Recipient Entity
Theia Clinic Rsrch Centers Llc
A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years No dispute reported 06/30/2026 1175187554
Principal investigator 1 Genentech, Inc. $929.00 04/11/2025 Non-covered Recipient Entity
THEIA CLINICAL RESEARCH CENTERS LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211672201
Principal investigator 1 Genentech, Inc. $1,858.00 04/04/2025 Non-covered Recipient Entity
THEIA CLINICAL RESEARCH CENTERS LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211672205
Principal investigator 1 Genentech, Inc. $4,645.00 04/02/2025 Non-covered Recipient Entity
THEIA CLINICAL RESEARCH CENTERS LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211672194
Principal investigator 1 Janssen Research & Development, LLC $1,073.64 03/24/2025 Non-covered Recipient Entity
Theia Clinic Rsrch Centers Llc
A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years No dispute reported 06/30/2026 1175187503
Principal investigator 1 Genentech, Inc. $2,787.00 03/21/2025 Non-covered Recipient Entity
THEIA CLINICAL RESEARCH CENTERS LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211672158
Principal investigator 1 Genentech, Inc. $2,787.00 02/28/2025 Non-covered Recipient Entity
THEIA CLINICAL RESEARCH CENTERS LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211672169
Principal investigator 1 Janssen Research & Development, LLC $279.88 02/19/2025 Non-covered Recipient Entity
Theia Clinic Rsrch Centers Llc
A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years No dispute reported 06/30/2026 1175187644
Principal investigator 1 Genentech, Inc. $2,787.00 02/05/2025 Non-covered Recipient Entity
THEIA CLINICAL RESEARCH CENTERS LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211672166
Principal investigator 1 Genentech, Inc. $2,787.00 02/05/2025 Non-covered Recipient Entity
THEIA CLINICAL RESEARCH CENTERS LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211672175
Principal investigator 1 PFIZER INC. $3,000.00 02/05/2025 Non-covered Recipient Entity
Theia Clinical Research Centers LLC
A MULTICENTER RANDOMIZED DOUBLEBLIND PARALLELGROUP STUDY TO ASSESS THE EFFICACY AND SAFETY OF ORAL ETRASIMOD AS INDUCTION AND MAINTENANCE THERAPY FOR MODERATELY TO SEVERELY ACTIVE CROHNS DISEASE No dispute reported 06/30/2026 1228774795
Principal investigator 1 PFIZER INC. $250.00 02/05/2025 Non-covered Recipient Entity
Theia Clinical Research Centers LLC
A MULTICENTER RANDOMIZED DOUBLEBLIND PARALLELGROUP STUDY TO ASSESS THE EFFICACY AND SAFETY OF ORAL ETRASIMOD AS INDUCTION AND MAINTENANCE THERAPY FOR MODERATELY TO SEVERELY ACTIVE CROHNS DISEASE No dispute reported 06/30/2026 1228777151
Principal investigator 1 PFIZER INC. $2,500.00 02/05/2025 Non-covered Recipient Entity
Theia Clinical Research Centers LLC
A MULTICENTER RANDOMIZED DOUBLEBLIND PARALLELGROUP STUDY TO ASSESS THE EFFICACY AND SAFETY OF ORAL ETRASIMOD AS INDUCTION AND MAINTENANCE THERAPY FOR MODERATELY TO SEVERELY ACTIVE CROHNS DISEASE No dispute reported 06/30/2026 1228784777
Principal investigator 1 Janssen Research & Development, LLC $7,803.98 01/24/2025 Non-covered Recipient Entity
Theia Clinic Rsrch Centers Llc
A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years No dispute reported 06/30/2026 1175187616
Principal investigator 1 Janssen Research & Development, LLC $17,377.24 01/24/2025 Non-covered Recipient Entity
Theia Clinic Rsrch Centers Llc
A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years No dispute reported 06/30/2026 1175187683
Principal investigator 1 Janssen Research & Development, LLC $839.64 01/21/2025 Non-covered Recipient Entity
Theia Clinic Rsrch Centers Llc
A Study of Vaccination With 9valent Extraintestinal Pathogenic Escherichia Coli Vaccine ExPEC9V in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years No dispute reported 06/30/2026 1175187714